Evidence map›Paper›PMID 38769965›Full record

ArticleRSC advances2024

Pilot-scale co-precipitation synthesis of a novel active ingredient made of ultrasmall iron (oxyhydr)oxide nanoparticles for the treatment of hyperphosphatemia.

Magdalena Teresa Spicher, Sebastian Patrick Schwaminger, Daniela von der Haar-Leistl, Marian Montiel Peralta, Georgina Mikacevic, Friedrich Ernst Wagner, Sonja Berensmeier

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Magdalena Teresa SpicherFraunhofer Institute for Process Engineering and Packaging (IVV) Giggenhauser Str. 35 85354 Freising Germany magdalena.spicher@ivv.fraunhofer.de +49 8161 491459.ORCID https://orcid.org/0000-0002-6171-6147
Sebastian Patrick SchwamingerChair of Bioseparation Engineering, School of Engineering and Design, Technical University of Munich Boltzmannstraße 15 85748 Garching Germany.ORCID https://orcid.org/0000-0002-8627-0807
Daniela von der Haar-LeistlFraunhofer Institute for Process Engineering and Packaging (IVV) Giggenhauser Str. 35 85354 Freising Germany magdalena.spicher@ivv.fraunhofer.de +49 8161 491459.
Marian Montiel PeraltaFraunhofer Institute for Process Engineering and Packaging (IVV) Giggenhauser Str. 35 85354 Freising Germany magdalena.spicher@ivv.fraunhofer.de +49 8161 491459.
Georgina MikacevicFraunhofer Institute for Process Engineering and Packaging (IVV) Giggenhauser Str. 35 85354 Freising Germany magdalena.spicher@ivv.fraunhofer.de +49 8161 491459.
Friedrich Ernst WagnerDepartment of Physics, Technical University of Munich James-Franck-Straße 1 85748 Garching Germany.
Sonja BerensmeierChair of Bioseparation Engineering, School of Engineering and Design, Technical University of Munich Boltzmannstraße 15 85748 Garching Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to its simplicity, co-precipitation is the most commonly used method for producing iron (oxyhydr)oxide nanoparticles. However, it is reported to be sensitive to changes in process parameters, which complicates scale-up and is why only volumes up to 1.2 L have been described in the literature. This study aims to demonstrate the scale-up of a co-precipitation synthesis to 100 L using the example of a new phosphate-binding active ingredient based on iron (oxyhydr)oxide. The synthesis was shown to be very robust to changes in synthesis parameters and stirrer geometries. The

Identifiers

PMID38769965
PMCPMC11103348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.